MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
20.04
+0.54 (2.77%)
Feb 5, 2025, 11:45 AM EST - Market open
MediWound Employees
MediWound had 100 employees as of December 31, 2023. The number of employees increased by 17 or 20.48% compared to the previous year.
Employees
100
Change (1Y)
17
Growth (1Y)
20.48%
Revenue / Employee
$197,200
Profits / Employee
-$280,590
Market Cap
216.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
MDWD News
- 2 months ago - MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - MediWound Is A Healthy Investment - Seeking Alpha
- 4 months ago - MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers - GlobeNewsWire
- 6 months ago - MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns - GlobeNewsWire
- 6 months ago - MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 6 months ago - MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT) - GlobeNewsWire